Northland Capmk Issues Negative Forecast for DocGo Earnings

DocGo Inc. (NASDAQ:DCGO) – Investment analysts at Northland Capmk lowered their FY2025 EPS estimates for DocGo in a research note issued on Monday, November 10th. Northland Capmk analyst M. Latimore now forecasts that the company will post earnings per share of ($0.53) for the year, down from their prior forecast of ($0.36). The consensus estimate for DocGo’s current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo’s Q4 2025 earnings at ($0.11) EPS, Q1 2026 earnings at ($0.05) EPS, Q2 2026 earnings at ($0.04) EPS and FY2026 earnings at ($0.09) EPS.

Other equities research analysts have also recently issued research reports about the stock. Canaccord Genuity Group dropped their price target on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a research report on Wednesday. Zacks Research upgraded DocGo from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of DocGo in a report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $3.21.

DocGo Price Performance

Shares of DCGO traded down $0.03 during midday trading on Thursday, hitting $1.06. 169,881 shares of the company traded hands, compared to its average volume of 1,118,377. The stock has a 50-day moving average of $1.30 and a 200-day moving average of $1.49. DocGo has a one year low of $0.97 and a one year high of $5.68. The firm has a market cap of $103.19 million, a P/E ratio of -2.03 and a beta of 0.93.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings data on Monday, November 10th. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02). DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%.The company had revenue of $70.81 million for the quarter, compared to the consensus estimate of $69.96 million. DocGo has set its FY 2025 guidance at EPS.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of DCGO. Bank of New York Mellon Corp raised its stake in shares of DocGo by 8.1% during the first quarter. Bank of New York Mellon Corp now owns 365,468 shares of the company’s stock valued at $965,000 after acquiring an additional 27,309 shares during the last quarter. Victory Capital Management Inc. raised its position in shares of DocGo by 546.1% in the first quarter. Victory Capital Management Inc. now owns 372,487 shares of the company’s stock valued at $983,000 after purchasing an additional 314,838 shares during the period. Jefferies Financial Group Inc. increased its stake in DocGo by 6,874.1% in the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company’s stock worth $5,358,000 after acquiring an additional 2,000,356 shares during the last quarter. Nuveen LLC bought a new stake in shares of DocGo in the 1st quarter worth approximately $649,000. Finally, Russell Investments Group Ltd. raised its position in DocGo by 59.0% during the 1st quarter. Russell Investments Group Ltd. now owns 229,213 shares of the company’s stock valued at $605,000 after purchasing an additional 85,097 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.